Simultaneous determination of metformin and rosiglitazone in human plasma by LC-MS/MS and the pharmacokinetics studies

Journal of China Pharmaceutical University

Volumn 38, Issue 3, 2007, Pages 247-251

  Zhang, Lu ^a   Tian, Yuan ^a   Zhang, Zun Jian ^a   Chen, Yun ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b INSTITUTE OF DERMATOLOGY   (China)

Author keywords

LC MS MS; Metformin; Pharmacokinetics; Rosiglitazone

Indexed keywords

ACETONITRILE; METFORMIN; PHENFORMIN; ROSIGLITAZONE;

AREA UNDER THE CURVE; ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DOSE COMPARISON; DRUG HALF LIFE; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PLASMA; STANDARD; VOLUNTEER;

EID: 34447124032     PISSN: 10005048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Jiang YY, Mao DZ, Huang RQ. Chin J Clin Pharm, 2004, 13(6):338-341.
2. Shi XJ, Zhang JH, Yin QP. Chin J Pharm Anal, 2004, 24(2):184-187.
3. Zhong GP, Bi HC, Zhou SF, et al. Simultaneous determination of metformin and gliclazide in human plasma by liquid chromatogaphy-tandem mass spectrometry: application to a bioequivalence study of two formulations in healthy volunteers [J]. J Mass Spectrometry, 2005, 40(11):1462-1471.
4. Ding YB, Zhang ZJ, Tian Y, J China Pharm Univ, 2003, 34(5): 438-441.
5. Zhou YW, Jiang WZ, Kong XL. Chin Pharm J, 2003, 38(7):523-525.